Proteasome Inhibitors (adverse effects) < Protective Factors (MeSH) < Protein Binding (MeSH)

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by Protective Factors (MeSH)

Number of relevant bibliographic references: 8.

Ident.	Authors (with country if any)	Title
000025 (2021)	Francisco Tejada Cifuentes [Espagne] ; Ángeles Lloret Callejo [Espagne] ; María José Tirado Peláez [Espagne] ; Olga Rubio Pulido [Espagne] ; Marta Ruiz-Morote Arag N [Espagne] ; Rocío Fernández Urrusuno [Espagne] ; María Isabel Mu Oz Carreras [Espagne] ; María Isabel Méndez Esteban [Espagne] ; Victoria Maestre Sánchez [Espagne] ; Antonio García Bonilla [Espagne] ; José Manuel Paredero Dominguez [Espagne] ; Virginia Arroyo Pineda [Espagne] ; Esther Marco Tej N [Espagne] ; Gregorio Romero Candel [Espagne] ; Ana Isabel Fernández Marchante [Espagne] ; José Marco Del Rio [Espagne] ; Teresa Ortiz Martín [Espagne] ; Piedad L Pez Sánchez [Espagne]	[Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine].
000120 (2021)	Giancarlo Ceccarelli [Italie] ; Francesco Alessandri [Italie] ; Alessandra Oliva [Italie] ; Serena Dell'Isola [Italie] ; Monica Rocco [Italie] ; Franco Ruberto [Italie] ; Francesco Pugliese [Italie] ; Gabriella D'Ettorre [Italie] ; Mario Venditti [Italie]	Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent.
000C82 (2020)	K H Lee [Corée du Sud] ; J S Kim ; S H Hong ; D. Seong ; Y R Choi ; Y T Ahn ; K S Kim ; S E Kim ; S. Lee ; W. Sim ; D. Kim ; B. Jun ; J W Yang ; D K Yon ; S W Lee ; M S Kim ; E. Dragioti ; H. Li ; L. Jacob ; A. Koyanagi ; R. Abou Ghayda ; J I Shin ; L. Smith	Risk factors of COVID-19 mortality: a systematic review of current literature and lessons from recent retracted articles.
001195 (2020)	Raquel González [Espagne, Mozambique] ; Laura García-Otero [Espagne, Mozambique] ; Clara Pons-Duran [Espagne] ; Elena Marbán-Castro [Espagne] ; Anna Goncé [Espagne] ; Elisa Llurba [Espagne] ; Maria Del Mar Gil [Espagne] ; Miguel Ngel Rodríguez-Zambrano [Espagne] ; Haily Chen [Espagne] ; Máximo Ramírez [Espagne] ; Azucena Bardají [Espagne, Mozambique] ; Clara Menendez [Espagne, Mozambique]	Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
001263 (2020)	Pranab Chatterjee [Inde] ; Tanu Anand [Inde] ; Kh Jitenkumar Singh [Inde] ; Reeta Rasaily [Inde] ; Ravinder Singh [Inde] ; Santasabuj Das [Inde] ; Harpreet Singh [Inde] ; Ira Praharaj [Inde] ; Raman R. Gangakhedkar [Inde] ; Balram Bhargava [Inde] ; Samiran Panda [Inde]	Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19.
001488 (2020)	Estibaliz Molina-Iturritza [Espagne] ; Irene San-José-Mu Iz [Espagne] ; Maite Ganchegui-Aguirre [Espagne] ; Leire Balerdi-Sarasola [Espagne] ; Zuri E Ortiz-De-Zárate-Ibarra [Espagne] ; Juan C. Gainzarain-Arana [Espagne] ; Joseba Portu-Zapirain [Espagne]	Coronavirus disease 2019 in patients with HIV in the province of Araba, Basque Country, Spain.
001641 (2020)	Carmel M. Mceniery [Royaume-Uni] ; Marie Fisk [Royaume-Uni] ; Karen Miles [Royaume-Uni] ; Fotini Kaloyirou [Royaume-Uni] ; Annette Hubsch [Royaume-Uni] ; Jane Smith [Royaume-Uni] ; Ian B. Wilkinson [Royaume-Uni] ; Joseph Cheriyan [Royaume-Uni]	ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
001648 (2020)	Milena Gianfrancesco [États-Unis] ; Kimme L. Hyrich [Royaume-Uni] ; Sarah Al-Adely [Royaume-Uni] ; Loreto Carmona [Espagne] ; Maria I. Danila [États-Unis] ; Laure Gossec [France] ; Zara Izadi [États-Unis] ; Lindsay Jacobsohn [États-Unis] ; Patricia Katz [États-Unis] ; Saskia Lawson-Tovey [Royaume-Uni] ; Elsa F. Mateus [Portugal] ; Stephanie Rush [États-Unis] ; Gabriela Schmajuk [États-Unis] ; Julia Simard [États-Unis] ; Anja Strangfeld [Allemagne] ; Laura Trupin [États-Unis] ; Katherine D. Wysham [États-Unis] ; Suleman Bhana [États-Unis] ; Wendy Costello [Irlande (pays)] ; Rebecca Grainger [Nouvelle-Zélande] ; Jonathan S. Hausmann [États-Unis] ; Jean W. Liew [États-Unis] ; Emily Sirotich [Canada] ; Paul Sufka [États-Unis] ; Zachary S. Wallace [États-Unis] ; Jinoos Yazdany [États-Unis] ; Pedro M. Machado [Royaume-Uni] ; Philip C. Robinson [Australie]	Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Protective Factors (MeSH)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Protective Factors (MeSH)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Protective Factors (MeSH)
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021